Cargando…

The effect of inhibition of the Na(+)/H(+) exchanger on the development of hypertrophy in hypertrophic cardiomyopathy

Detalles Bibliográficos
Autores principales:	Brouwer, Wessel P, Houweling, Arjan C, Nederhoff, Marcel G, Germans, Tjeerd, van Borren, Marcel M, Pasterkamp, Gerard, van der Velden, Jolanda, van Rossum, Albert C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3106480/ http://dx.doi.org/10.1186/1532-429X-13-S1-P290

Ejemplares similares

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness
por: Rüssel, Iris K, et al.
Publicado: (2011)

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2014)

Regional myocardial function at preclinical disease stage of hypertrophic cardiomyopathy in female gene variant carriers
por: Parbhudayal, Rahana Y., et al.
Publicado: (2021)

Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic TNNT2 Gene Variants
por: Parbhudayal, Rahana Y., et al.
Publicado: (2020)

How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance
por: Germans, Tjeerd, et al.
Publicado: (2010)

Increased sarcolemmal Na(+)/H(+) exchange activity in hypertrophied myocytes from dogs with chronic atrioventricular block
por: van Borren, Marcel M. G. J., et al.
Publicado: (2013)

Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Scientists on the spot: Relaxing the heart in hypertrophic cardiomyopathy
por: Gladka, Monika M, et al.
Publicado: (2023)

CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation
por: Papavassiliu, Theano, et al.
Publicado: (2009)

Elevated high-sensitivity cardiac troponin is associated with hypertrophy and fibrosis assessed with CMR in patients with hypertrophic cardiomyopathy
por: Gommans, Frank, et al.
Publicado: (2013)

(23)Na chemical shift imaging and Gd enhancement of myocardial edema
por: Aguor, Eissa N. E., et al.
Publicado: (2012)

Hypertrophic cardiomyopathy with little hypertrophy and severe arrhythmia
por: Ripoll-Vera, Tomas, et al.
Publicado: (2018)

ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study)
por: Güçlü, A., et al.
Publicado: (2013)

Myocardial adaptation after surgical therapy differs for aortic valve stenosis and hypertrophic obstructive cardiomyopathy
por: Parbhudayal, Rahana Y., et al.
Publicado: (2019)

Translational investigation of electrophysiology in hypertrophic cardiomyopathy
por: Flenner, Frederik, et al.
Publicado: (2021)

FHL2 expression and variants in hypertrophic cardiomyopathy
por: Friedrich, Felix W., et al.
Publicado: (2014)

Transcriptional bursts and heterogeneity among cardiomyocytes in hypertrophic cardiomyopathy
por: Burkart, Valentin, et al.
Publicado: (2022)

Subaortic and midventricular obstructive hypertrophic cardiomyopathy with extreme segmental hypertrophy
por: Efthimiadis, Georgios K, et al.
Publicado: (2007)

Extreme septal hypertrophy in an adolescent with congenital familial hypertrophic cardiomyopathy
por: Park, Byoung-Won, et al.
Publicado: (2015)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
por: Park, Kyoung-min, et al.
Publicado: (2016)

Exercise and myocardial injury in hypertrophic cardiomyopathy
por: Cramer, G Etienne, et al.
Publicado: (2020)

Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy
por: Dorsch, Larissa M., et al.
Publicado: (2019)

Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier
por: Nollet, Edgar E., et al.
Publicado: (2020)

Blood‐based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta‐analysis
por: Jansen, Mark, et al.
Publicado: (2022)

Calcium Transient and Sodium-Calcium Exchange Current in Human versus Rabbit Sinoatrial Node Pacemaker Cells
por: Verkerk, Arie O., et al.
Publicado: (2013)

Sex-specific cardiac remodeling in early and advanced stages of hypertrophic cardiomyopathy
por: Nijenkamp, Louise L. A. M., et al.
Publicado: (2020)

Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy
por: CIAMPI, QUIRINO, et al.
Publicado: (2006)

Cardiotrophin-1 plasma levels are associated with the severity of hypertrophy in hypertrophic cardiomyopathy
por: Monserrat, Lorenzo, et al.
Publicado: (2011)

Electro‐ and echocardiographic features of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy
por: Bula, Karolina, et al.
Publicado: (2022)

Correlation between septal midwall late gadolinium enhancement on CMR and conduction delay on ECG in patients with nonischemic dilated cardiomyopathy
por: Becker, Marthe A.J., et al.
Publicado: (2020)

Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy
por: Schuldt, Maike, et al.
Publicado: (2021)

Five-year prognostic significance of global longitudinal strain in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes
por: van Velzen, H. G., et al.
Publicado: (2019)

MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy
por: McNamara, James W., et al.
Publicado: (2017)

Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy
por: Fluechter, Stephan, et al.
Publicado: (2010)

Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients
por: Reza, Nosheen, et al.
Publicado: (2021)

Reversible Apical Hypertrophy in a Young Competitive Athlete with Familiar Hypertrophic Cardiomyopathy
por: Di Gioia, Giuseppe, et al.
Publicado: (2023)

Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy
por: Hermida, Uxio, et al.
Publicado: (2022)

Metabolomics in Severe Aortic Stenosis Reveals Intermediates of Nitric Oxide Synthesis as Most Distinctive Markers
por: van Driel, Beau Olivier, et al.
Publicado: (2021)

Assessment of prognostic LV parameters with CMR in hypertrophic cardiomyopathy: impact of the papillary muscles
por: Gommans, Frank, et al.
Publicado: (2012)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sf9vu5a73p65usdt5gvr4vg86c